We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-4.45%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.08B
AUM Growth
+$322M
Cap. Flow
+$648M
Cap. Flow %
21%
Top 10 Hldgs %
37.4%
Holding
321
New
89
Increased
78
Reduced
45
Closed
96

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$32M
2
CCCC icon
C4 Therapeutics
CCCC
+$14.5M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$14.1M
4
AMRS
Amyris Inc.
AMRS
+$11M
5
TECH icon
Bio-Techne
TECH
+$10.3M

Top Sells

Rank Stock Value
1
NTRA icon
Natera
NTRA
+$14.1M
2
DXCM icon
DexCom
DXCM
+$14.1M
3
ICUI icon
ICU Medical
ICUI
+$14M
4
LIVN icon
LivaNova
LIVN
+$12.2M
5
OLPX
Olaplex Holdings
OLPX
+$11.6M

Sector Composition

Rank Sector Weight
1 Healthcare 24.06%
2 Materials 0.35%
3 Industrials 0.17%
4 Consumer Discretionary 0.07%
5 Financials 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INSM icon
251
Insmed
INSM
$28.9B
– –
-19,713
Closed -$537K
IONS icon
252
Ionis Pharmaceuticals
IONS
$9.39B
– –
-48,544
Closed -$1.48M
IPHA
253
Innate Pharma
IPHA
$232M
– –
-79,896
Closed -$364K
ISRG icon
254
PUT
Intuitive Surgical
ISRG
$142B
– –
-20,000
Closed -$7.19M
KOD icon
255
Kodiak Sciences
KOD
$2.72B
– –
-12,115
Closed -$1.03M
KOD icon
256
PUT
Kodiak Sciences
KOD
$2.72B
– –
-29,100
Closed -$2.47M
KRYS icon
257
PUT
Krystal Biotech
KRYS
$9.85B
– –
-12,100
Closed -$846K
KURA icon
258
Kura Oncology
KURA
$882M
– –
-89,612
Closed -$1.25M
LUV icon
259
PUT
Southwest Airlines
LUV
$22B
– –
-295,700
Closed -$12.7M
MRK icon
260
CALL
Merck
MRK
$328B
– –
-62,300
Closed -$4.78M
MRK icon
261
Merck
MRK
$328B
– –
-24,246
Closed -$1.86M
MRNA icon
262
PUT
Moderna
MRNA
$25.4B
– –
-23,200
Closed -$5.89M
NEO icon
263
PUT
NeoGenomics
NEO
$2.11B
– –
-295,700
Closed -$10.1M
NKTR icon
264
PUT
Nektar Therapeutics
NKTR
$2.57B
– –
-18,905
Closed -$3.83M
NTRA icon
265
Natera
NTRA
$45.5B
– –
-235,199
Closed -$14.1M
OHI icon
266
PUT
Omega Healthcare
OHI
$13.9B
– –
-246,400
Closed -$7.29M
OLMA icon
267
Olema Pharmaceuticals
OLMA
$913M
– –
-93,330
Closed -$874K
OLPX
268
DELISTED
Olaplex Holdings
OLPX
– –
-399,906
Closed -$11.6M
ORGO icon
269
PUT
Organogenesis Holdings
ORGO
$233M
– –
-345,000
Closed -$3.19M
PACB icon
270
Pacific Biosciences
PACB
$345M
– –
-330,033
Closed -$3.8M
PFE icon
271
Pfizer
PFE
$150B
– –
-152,273
Closed -$8.99M
PIFI icon
272
PUT
ClearShares Piton Intermediate Fixed Income ETF
PIFI
$97.8M
– –
-246,400
Closed -$5.2M
PRCT icon
273
Procept Biorobotics
PRCT
$1.22B
– –
-155,214
Closed -$3.88M
QNCX icon
274
PUT
Quince Therapeutics
QNCX
$31.8M
– –
-194
Closed -$490K
QTRX icon
275
Quanterix
QTRX
$139M
– –
-292,877
Closed -$8.95M
9 10
11
12 13

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q1 2022 Portfolio in Review

As of Q1 2022, Pura Vida Investments held 321 positions worth $3.08B, up 12% from $2.76B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Pura Vida Investments deployed $648M of net new capital in Q1 2022, opening 89 new positions and adding to 78 existing holdings. Its largest new stake was Biogen: 147,135 shares worth $31M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 30% a quarter earlier, followed by Materials and Industrials.

On the sell side, the largest reduction was ICU Medical, an estimated $14M trimmed.

  • Pura Vida Investments's largest Q1 2022 buy was Biogen: 147,135 shares worth $31M.
  • Pura Vida Investments added most to C4 Therapeutics in Q1 2022, an estimated $14.5M increase.
  • Pura Vida Investments's biggest Q1 2022 reduction was ICU Medical, cutting an estimated $14M.
  • Pura Vida Investments fully exited Natera in Q1 2022, selling an estimated $14.1M.
  • Pura Vida Investments's ten largest holdings make up 37% of its $3.08B portfolio in Q1 2022.
  • Pura Vida Investments opened 89 new positions and closed 96 in Q1 2022.
  • Pura Vida Investments's portfolio value rose 12% quarter-over-quarter to $3.08B.

Based on Pura Vida Investments's 13F filing for Q1 2022, filed 16 May 2022.